Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent agony products and is also existing at micromolar amounts during the brain after systemic injection. Conolidine CONOCB2™ basically is effective by making a barrier between the opioid receptors in the brain and the "scavenger" receptors in the human body, https://richardz357okz2.blogsvirals.com/profile